Filing Details
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event.
8k filedNASDAQ:TCRT
Alaunos Therapeutics, Inc. (TCRT) Reports Material Event to SEC
Filing Details Alaunos Therapeutics, Inc. (NASDAQ:TCRT) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event. Market Context…
Market Context
Alaunos Therapeutics, Inc.'s stock currently trades at $2.37 with a market capitalization of $9.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Alaunos Therapeutics, Inc.'s stock.
All SEC filings for Alaunos Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TCRT Stock Page
Frequently Asked Questions
Where can I read TCRT's SEC filings?
Browse all filings on our TCRT SEC filings page.
What types of SEC filings does Alaunos Therapeutics, Inc. file?
Public companies like Alaunos Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.